```TEXT

Novera Retatru & Duro: A Joint Process Strategy? Innovative data suggest a possible combination between Novo Retat, a novel dual agonist for GLP-1, and Dural, a hyaluron substance delivery. While Retatrutide targets sugar disorder and fat management, Dural offers joint moistening and di